Read + Share
Watanabe D, Fujii H, Ohata K, Iihara H, et al. Prognostic impact of severe neutropenia in colorectal cancer patients treated
with TAS-102 and bevacizumab, addressing immortal-time bias. BMC Cancer 2023;23:1078.
PMID: 37940878
|
 |
|
Watanabe D, Fujii H, Ohata K, Iihara H, et al. Prognostic impact of severe neutropenia in colorectal cancer patients treated
with TAS-102 and bevacizumab, addressing immortal-time bias. BMC Cancer 2023;23:1078.
PMID: 37940878
|
|
|
|